Sunitinib malate and Duphalac drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sunitinib malate (sunitinib malate) and Duphalac (lactulose). Common drug interactions include cardiac failure among females and pleural effusion among males.

The phase IV clinical study analyzes what interactions people have when they take Sunitinib malate and Duphalac. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Sunitinib malate?

Sunitinib malate has active ingredients of sunitinib malate. eHealthMe is studying from 9,160 Sunitinib malate users. Check the latest studies of Sunitinib malate.

What is Duphalac?

Duphalac has active ingredients of lactulose. It is often used in constipation. eHealthMe is studying from 5,152 Duphalac users. Check the latest studies of Duphalac.

On Aug, 02, 2026

18 people who take Sunitinib malate and Duphalac together, and have interactions are studied.

Sunitinib malate and Duphalac drug interactions.

What are the common drug interactions of Sunitinib Malate and Duphalac, by gender? *:

female:

Cardiac failure
Hypertension (high blood pressure)
Ischaemic stroke (stroke; caused by an interruption in the flow of blood to the brain)
Malaise (a feeling of general discomfort or uneasiness)
Vomiting

male:

Pleural effusion (water on the lungs)
Asthenia (weakness)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
General physical health deterioration (weak health status)
Neurological symptom (symptoms of nervous system disease)
Pain
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
Polycythaemia (proportion of blood volume that is occupied by red blood cells increases)
Pulmonary embolism (blockage of the main artery of the lung)
Sleep disorder due to general medical condition, insomnia type (a conditions that prevent a person from getting restful sleep due to mental condition of not getting sleep)

What are the common drug interactions of Sunitinib Malate and Duphalac, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Dyspepsia (indigestion)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Pleural effusion (water on the lungs)
Sleep disorder due to general medical condition, insomnia type (a conditions that prevent a person from getting restful sleep due to mental condition of not getting sleep)

40-49:

Pleural effusion (water on the lungs)
Decreased appetite
Disease progression
Nausea (feeling of having an urge to vomit)
Non-small cell lung cancer (type of epithelial lung cancer)
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
Weight decreased

50-59:

n/a

60+:

Asthenia (weakness)
Cardiac failure
General physical health deterioration (weak health status)
Hypertension (high blood pressure)
Ischaemic stroke (stroke; caused by an interruption in the flow of blood to the brain)
Malaise (a feeling of general discomfort or uneasiness)
Neurological symptom (symptoms of nervous system disease)
Pain
Polycythaemia (proportion of blood volume that is occupied by red blood cells increases)
Pulmonary embolism (blockage of the main artery of the lung)

What are the existing conditions these people have? *

Renal Cell Carcinoma (a kidney cancer): 9 people, 50.00%
Bone Pain: 5 people, 27.78%
Enlarged Prostate: 5 people, 27.78%
Headache (pain in head): 5 people, 27.78%
Laxative Supportive Care: 5 people, 27.78%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 3 people, 16.67%
Gastrointestinal Stromal Tumor: 3 people, 16.67%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 16.67%
High Blood Pressure: 2 people, 11.11%
Indigestion: 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Sunitinib malate and Duphalac?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously